From trust to tap: NFC technology reshapes packaging’s role in authentication and engagement

Patient trust is no longer assumed — it must be verified.

Across the pharmaceutical industry, a convergence of regulatory pressure, globalized supply chains, and rising counterfeiting activity is forcing companies to rethink the role of packaging. The result is a fundamental shift: labels and cartons are no longer just identifiers — they are becoming active participants in product authentication, data integrity, and patient safety.

Recent enforcement actions highlight the urgency. As part of Interpol’s Operation Pangea XVII, more than 50 million illicit doses of medication were seized globally in 2025, underscoring the scale and sophistication of pharmaceutical counterfeiting. Increasingly, these products arrive in convincing, high-quality packaging, making visual inspection alone insufficient.

At the same time, new frameworks — including evolving EU pharmaceutical legislation, Digital Product Passport initiatives, and expanded FDA oversight — are placing greater emphasis on traceability and digital auditability throughout the product lifecycle.

In this environment, packaging is being asked to do more. And increasingly, Near Field Communication (NFC) technology is emerging as a key enabler.

Closing the Authentication Gap

While RFID has long supported supply chain visibility through automated tracking and inventory management, NFC operates at a different — and increasingly critical — level. By enabling secure, short-range communication via smartphones and dedicated readers, NFC creates a direct link between the physical product and a verified digital identity.

That capability is reshaping how brands approach authentication.

“Trust in physical products can’t be assumed anymore — it has to be verified,” says Andreas Walsner, global vice president of sales at Identiv. “NFC-based identity and tamper detection allow companies to confirm authenticity and product integrity at any point in the lifecycle.”

Identiv’s expanded ID-Safe portfolio reflects this shift. The platform combines NFC-enabled tags with tamper-evident and tamper-proof design features, including destructible antennas that prevent reuse and refilling, and encrypted chips that guard against cloning. Each tag carries a unique digital identity that can be linked to cloud-based systems, effectively creating a digital twin of the product.

Once deployed, that system provides real-time visibility. If a package is opened, altered, or scanned in an unexpected location, the event is recorded and flagged — offering a level of transparency that traditional labeling simply cannot match.

For pharmaceutical applications, this capability is particularly critical. NFC can be integrated with tamper-evident structures in secondary packaging, helping to prevent refilling or reuse of legitimate containers—an increasingly common tactic in counterfeit operations.

From Experimental to Essentia

Despite its potential, NFC has historically struggled to gain traction in pharmaceutical packaging. Concerns around manufacturing disruption, cost, and overall equipment effectiveness (OEE) kept the technology largely in a pilot phase.

That equation is changing.

Advances in chip design, antenna engineering, and materials science have dramatically reduced both the cost and complexity of NFC integration. Today’s components are thinner, more flexible, and easier to embed within labels and cartons — often without requiring significant modifications to existing converting or packing lines.

That progress is evident in recent developments from Tageos and Pragmatic Semiconductor, which have introduced new FlexIC-based NFC inlays designed specifically for high-volume packaging applications.

The EOS Lite and EOS Zero Lite product families leverage ultra-thin flexible chips and paper-based antenna designs to deliver both performance and sustainability benefits. The first product in the series—a paper-based NFC inlay — has been engineered for seamless integration into labels and paper packaging, supporting recyclability while maintaining the functionality required for authentication and consumer interaction.

For converters, the implications are significant.

By minimizing material usage and enabling discreet integration, these next-generation inlays allow NFC functionality to be incorporated into existing label constructions without compromising appearance, performance, or production efficiency.

“Our goal is to enable scalable, cost-effective NFC solutions that can be integrated without disruption,” says Matthieu Picon, CEO of Tageos. “This opens new possibilities for brands to connect directly with consumers through packaging.”

A New Layer of Intelligence

As NFC adoption accelerates, the role of the label is expanding beyond identification and compliance.

At its core, NFC enables what many in the industry now describe as “item-level intelligence”—the ability for each individual product to carry a unique, interactive digital identity.

That identity can serve multiple functions simultaneously:

• Authentication – verifying that a product is genuine
• Integrity monitoring – confirming that packaging has not been opened or altered
• Traceability – linking products to supply chain data and audit trails
• Engagement – enabling direct interaction between brands and consumers

In pharmaceutical applications, this intelligence supports closed-loop verification across the entire value chain. For example, multi-layer authentication systems can incorporate hidden NFC tags for manufacturers and distributors, alongside visible tags for patient use. Each interaction — whether during aggregation, distribution, or end use — can be recorded and validated.

The result is a continuous chain of trust.

Beyond security, NFC also introduces new opportunities for patient-centric design. Smart packaging can deliver spoken instructions, multilingual content, and accessibility features through a simple smartphone tap. In some applications, electronic blister packs can even record when medication is accessed, supporting adherence tracking and patient care.

These capabilities reflect a broader shift: packaging is no longer just protecting the product—it is supporting the user experience.

Beyond Pharma: A Broader Packaging Opportunity

While pharmaceutical applications are driving much of the urgency around NFC adoption, the technology’s impact is extending far beyond healthcare.

Across sectors—including food and beverage, luxury goods, and consumer packaged goods—brands are exploring NFC as a tool for authentication, storytelling, and consumer engagement.

The same core principles apply. As supply chains become more complex and digital transparency becomes a competitive advantage, the ability to connect physical products to digital ecosystems is becoming increasingly valuable.

For converters, this represents both a challenge and an opportunity.

Integrating NFC requires new considerations around materials, design, and production workflows. At the same time, it creates a pathway to higher-value offerings—transforming labels from a cost component into a strategic asset.

As regulatory initiatives such as Digital Product Passports continue to gain traction, the demand for connected packaging solutions is only expected to grow.

The Connected Future of Labels

The rise of NFC is part of a larger transformation taking place across the labeling and packaging industry.

Driven by regulation, sustainability goals, and evolving consumer expectations, packaging is becoming more intelligent, more interactive, and more accountable.

What was once considered a niche technology is quickly moving toward the mainstream.

For pharmaceutical companies, NFC offers a way to strengthen patient safety and restore trust in an increasingly complex market. For brand owners, it provides a direct channel to consumers. And for converters, it represents a new frontier—where innovation, functionality, and value creation converge.

In this new landscape, the label is no longer just something you see – it’s something you tap.